Anti-MEK1 + MEK2 (phospho S222) antibody
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Polyclonal MEK1 phospho S222 antibody. Suitable for WB, ICC/IF and reacts with Mouse, Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human MAP2K1 phospho S222.
View Alternative Names
MEK1, PRKMK1, MAP2K1, Dual specificity mitogen-activated protein kinase kinase 1, MAP kinase kinase 1, MAPKK 1, MKK1, ERK activator kinase 1, MAPK/ERK kinase 1, MEK 1
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-MEK1 + MEK2 (phospho S222) antibody (AB4750)
Immunofluorescent analysis of mouse embryonic fibroblasts labelled for MEK1/2 (pS222) using ab4750, phosphospecific antibody. The cell is actively dividing. Blue represents chromosomes in anaphase of mitotic cell division. Green shows mitotic spindle expressing phosphorylated MEK1/2.
- WB
Supplier Data
Western blot - Anti-MEK1 + MEK2 (phospho S222) antibody (AB4750)
Western blot analysis was performed on whole cell extracts of A549 in different conditions, observed a 45 kDa band corresponding to Phospho-MEK1/MEK2 (Ser222) was observed in untreated A549 lysate, the signal increased upon EGF treatment, and decreased upon pretreatment with the EGFR antagonist, Afatinib. Known quantity of protein samples were electrophoresed using Novex® NuPAGE® 4-12 % Bis-Tris gel, XCell SureLock™ Electrophoresis System and Novex® Sharp Pre-Stained Protein Standard. Resolved proteins were then transferred onto a nitrocellulose membrane with iBlot® 2 Dry Blotting System. The membrane was probed with the relevant primary and secondary Antibody following blocking with 5 % skimmed milk. Chemiluminescent detection was performed using Pierce™ ECL Western Blotting Substrate.
All lanes:
Western blot - Anti-MEK1 + MEK2 (phospho S222) antibody (ab4750)
Lane 1:
A549 whole cell extract lysate at 30 µg
Lane 2:
A549 whole cell lysate treated with EGF (200 ng/mL for 10 min) at 30 µg
Lane 3:
A549 whole cell lysate treated with Afatinib (0.5 uM for 16 h) followed by EGF (200 ng/mL for 10 min) at 30 µg
Secondary
All lanes:
Goat anti-Rabbit IgG (H+L) Superclonal™ Secondary Antibody, HRP conjugate at 0.25 µg/mL
Predicted band size: 43 kDa
false
- WB
Supplier Data
Western blot - Anti-MEK1 + MEK2 (phospho S222) antibody (AB4750)
Peptide Competition and Stimulation Extracts of NIH3T3 cells untreated (lane 1) or treated with 50 ng/mL PDGF for 15 minutes (2-5) were resolved by SDS-PAGE on a 10% Tris-glycine gel and transferred to PVDF. The membrane was blocked with a 4% BSA-TBST buffer overnight at 4°C, then incubated with the MEK1&2 (pS222) antibody for two hours at room temperature in a 1% BSA-TBST buffer, following various prior incubation conditions. After washing, the membrane was incubated with goat F (ab)2 anti-rabbit IgG alkaline phosphatase and signals were detected using the Pierce SuperSignal method. The data show that only the phosphopeptide corresponding to MEK1&2 (pS222) block the antibody signal, demonstrating the specificity of the antibody. The data also show the induction of MEK1&2 (pS222) phosphorylation by the addition of PDGF to this cell system.
All lanes:
Western blot - Anti-MEK1 + MEK2 (phospho S222) antibody (ab4750)
Lane 1:
Untreated NIH3T3 cells
Lane 2:
PDGF treated NIH3T3 cells, with no peptide incubation
Lane 3:
PDGF treated NIH3T3 cells, incubated with non-phosphopeptide immunogen
Lane 4:
PDGF treated NIH3T3 cells, incubated with generic phosphoserine peptide.
Lane 5:
PDGF treated NIH3T3 cells, incubated with phosphopeptide immunogen.
Secondary
All lanes:
A goat F (ab)2 anti-rabbit IgG alkaline phosphatase
Predicted band size: 43 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MEK1 and MEK2 are integral parts of the mitogen-activated protein kinase (MAPK) signaling cascade. MEK1/2 phosphorylate and activate the ERK1/2 kinases which transmit signals from the cell surface to the nucleus regulating gene expression and cell fate decisions. The MEK1/2 proteins also act in concert with other kinases and substrates forming signaling complexes that ensure specific and regulated cellular outcomes.
Pathways
MEK1 and MEK2 play key roles within the MAPK/ERK pathway a critical signaling mechanism for cell division and survival. They also link to the RAS/MAPK pathway involved in transmitting signals from membrane receptors to the nucleus. In these pathways MEK1/2 interact with proteins like RAF kinases and ERK1/2 propagating signals that influence cellular growth and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Journal of experimental & clinical cancer research : CR 44:68 PubMed39994761
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 8:eabl8809 PubMed35857446
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular bioengineering 12:301-310 PubMed31719916
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com